SHIEF
Price
$0.04
Change
+$0.01 (+33.33%)
Updated
Jun 27 closing price
Capitalization
98.52M
TLRY
Price
$0.65
Change
+$0.03 (+4.84%)
Updated
Aug 7 closing price
Capitalization
1.87B
55 days until earnings call
Interact to see
Advertisement

SHIEF vs TLRY

Header iconSHIEF vs TLRY Comparison
Open Charts SHIEF vs TLRYBanner chart's image
Shield Therapeutics
Price$0.04
Change+$0.01 (+33.33%)
Volume$10K
Capitalization98.52M
Tilray Brands
Price$0.65
Change+$0.03 (+4.84%)
Volume$15.91M
Capitalization1.87B
SHIEF vs TLRY Comparison Chart in %
Loading...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SHIEF vs. TLRY commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHIEF is a Buy and TLRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (SHIEF: $0.04 vs. TLRY: $0.65)
Brand notoriety: SHIEF: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SHIEF: 112% vs. TLRY: 44%
Market capitalization -- SHIEF: $98.52M vs. TLRY: $1.87B
SHIEF [@Pharmaceuticals: Other] is valued at $98.52M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SHIEF’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • SHIEF’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SHIEF is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHIEF’s TA Score shows that 2 TA indicator(s) are bullish while TLRY’s TA Score has 5 bullish TA indicator(s).

  • SHIEF’s TA Score: 2 bullish, 1 bearish.
  • TLRY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both SHIEF and TLRY are a good buy in the short-term.

Price Growth

SHIEF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while TLRY (@Pharmaceuticals: Other) price change was +11.98% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.

Reported Earning Dates

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than SHIEF($98.5M). SHIEF YTD gains are higher at: 11.594 vs. TLRY (-51.090). SHIEF has higher annual earnings (EBITDA): -21.41M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. SHIEF (2.4M). SHIEF has less debt than TLRY: SHIEF (0) vs TLRY (529M). TLRY has higher revenues than SHIEF: TLRY (700M) vs SHIEF (3.07M).
SHIEFTLRYSHIEF / TLRY
Capitalization98.5M1.87B5%
EBITDA-21.41M-1.23B2%
Gain YTD11.594-51.090-23%
P/E RatioN/A8.52-
Revenue3.07M700M0%
Total Cash2.4M260M1%
Total Debt0529M-
FUNDAMENTALS RATINGS
SHIEF vs TLRY: Fundamental Ratings
SHIEF
TLRY
OUTLOOK RATING
1..100
3779
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4451
P/E GROWTH RATING
1..100
9394
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for SHIEF (86) in the null industry. This means that TLRY’s stock grew somewhat faster than SHIEF’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SHIEF (100) in the null industry. This means that TLRY’s stock grew similarly to SHIEF’s over the last 12 months.

SHIEF's SMR Rating (97) in the null industry is in the same range as TLRY (98) in the Biotechnology industry. This means that SHIEF’s stock grew similarly to TLRY’s over the last 12 months.

SHIEF's Price Growth Rating (44) in the null industry is in the same range as TLRY (51) in the Biotechnology industry. This means that SHIEF’s stock grew similarly to TLRY’s over the last 12 months.

SHIEF's P/E Growth Rating (93) in the null industry is in the same range as TLRY (94) in the Biotechnology industry. This means that SHIEF’s stock grew similarly to TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SHIEFTLRY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
36%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
32%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
31%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
18%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFIVX25.750.24
+0.94%
DFA International Value I
FRLAX17.14N/A
N/A
Franklin Real Estate Securities Adv
LEISX23.59N/A
N/A
Federated Hermes Equity Income IS
FAPCX19.03N/A
N/A
Fidelity Intl Cptl Apprec K6
LIFLX15.14N/A
N/A
Lord Abbett Focused Large Cap Value I

SHIEF and

Correlation & Price change

A.I.dvisor tells us that SHIEF and TLRY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHIEF and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHIEF
1D Price
Change %
SHIEF100%
N/A
TLRY - SHIEF
28%
Poorly correlated
+5.40%
CGC - SHIEF
26%
Poorly correlated
N/A
ACB - SHIEF
25%
Poorly correlated
-0.59%
IMCC - SHIEF
25%
Poorly correlated
+1.99%
CVSI - SHIEF
20%
Poorly correlated
+3.75%
More